Rationality of routine clinical use of olokizumab in COVID-19
Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Izdatelstvo OKI
2020-10-01
|
| Series: | Качественная клиническая практика |
| Subjects: | |
| Online Access: | https://www.clinvest.ru/jour/article/view/530 |
| Summary: | Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials. |
|---|---|
| ISSN: | 2588-0519 2618-8473 |